Trevena Management
Management criteria checks 2/4
Trevena's CEO is Carrie Bourdow, appointed in Oct 2018, has a tenure of 6.17 years. total yearly compensation is $1.66M, comprised of 40.9% salary and 59.1% bonuses, including company stock and options. directly owns 0.24% of the company’s shares, worth $3.60K. The average tenure of the management team and the board of directors is 3.5 years and 10.4 years respectively.
Key information
Carrie Bourdow
Chief executive officer
US$1.7m
Total compensation
CEO salary percentage | 40.9% |
CEO tenure | 6.2yrs |
CEO ownership | 0.2% |
Management average tenure | 3.5yrs |
Board average tenure | 10.4yrs |
Recent management updates
Recent updates
Trevena Q2 2022 Earnings Preview
Aug 10Trevena slides on $2M preferred stock offering
Jul 29Trevena (NASDAQ:TRVN) Will Have To Spend Its Cash Wisely
Jul 08Is Trevena (NASDAQ:TRVN) In A Good Position To Deliver On Growth Plans?
Mar 19Trevena Offers An Enticing Risk-Reward At These Prices
Dec 14Trevena: Remaining Patient After A Disappointing Q2 Earnings
Aug 17Trevena announces resumption of NIH-run trial for TRV734 in opioid use disorder
Jun 16Trevena's OLINVYK Provides One Of The Most Compelling Growth Profiles
May 10Trevena Investor Presentation - Slideshow
May 08Trevena (TRVN) Investor Presentation - Slideshow
Nov 16Trevena: Reaffirming A Buy On OLINVYK DEA Scheduling
Nov 09DEA classifies Trevena's oliceridine, distribution to start in November
Oct 30CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Sep 30 2024 | n/a | n/a | -US$34m |
Jun 30 2024 | n/a | n/a | -US$37m |
Mar 31 2024 | n/a | n/a | -US$40m |
Dec 31 2023 | US$2m | US$682k | -US$40m |
Sep 30 2023 | n/a | n/a | -US$31m |
Jun 30 2023 | n/a | n/a | -US$38m |
Mar 31 2023 | n/a | n/a | -US$45m |
Dec 31 2022 | US$1m | US$656k | -US$54m |
Sep 30 2022 | n/a | n/a | -US$61m |
Jun 30 2022 | n/a | n/a | -US$59m |
Mar 31 2022 | n/a | n/a | -US$58m |
Dec 31 2021 | US$2m | US$637k | -US$52m |
Sep 30 2021 | n/a | n/a | -US$50m |
Jun 30 2021 | n/a | n/a | -US$41m |
Mar 31 2021 | n/a | n/a | -US$33m |
Dec 31 2020 | US$3m | US$613k | -US$29m |
Sep 30 2020 | n/a | n/a | -US$24m |
Jun 30 2020 | n/a | n/a | -US$27m |
Mar 31 2020 | n/a | n/a | -US$25m |
Dec 31 2019 | US$2m | US$563k | -US$25m |
Sep 30 2019 | n/a | n/a | -US$26m |
Jun 30 2019 | n/a | n/a | -US$22m |
Mar 31 2019 | n/a | n/a | -US$27m |
Dec 31 2018 | US$2m | US$418k | -US$31m |
Sep 30 2018 | n/a | n/a | -US$38m |
Jun 30 2018 | n/a | n/a | -US$49m |
Mar 31 2018 | n/a | n/a | -US$60m |
Dec 31 2017 | US$1m | US$341k | -US$72m |
Compensation vs Market: Carrie's total compensation ($USD1.66M) is above average for companies of similar size in the US market ($USD653.16K).
Compensation vs Earnings: Carrie's compensation has increased whilst the company is unprofitable.
CEO
Carrie Bourdow (61 yo)
6.2yrs
Tenure
US$1,664,855
Compensation
Ms. Carrie L. Bourdow has been Chief Executive Officer, President and Director at Trevena, Inc. since October 01, 2018 and serves as its Chairman since November 09, 2023. Ms. Bourdow served as an Executive...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
President | 6.2yrs | US$1.66m | 0.24% $ 3.6k | |
Chief Operating Officer | less than a year | US$1.01m | 0.15% $ 2.2k | |
Senior VP & Chief Medical Officer | 6.6yrs | US$1.03m | 0.22% $ 3.4k | |
Scientific Founder | no data | no data | no data | |
Principal Financial Officer & principal accounting officer | less than a year | no data | no data | |
Senior VP | less than a year | US$689.16k | 0.049% $ 739.2 | |
Vice President of Marketing | 6.8yrs | no data | no data |
3.5yrs
Average Tenure
58yo
Average Age
Experienced Management: TRVN's management team is considered experienced (3.5 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
President | 6.2yrs | US$1.66m | 0.24% $ 3.6k | |
Scientific Founder | no data | no data | no data | |
Member of Scientific Advisory Board | no data | no data | no data | |
Member of the Scientific Advisory Board | 15.9yrs | no data | no data | |
Member of Scientific Advisory Board | no data | no data | no data | |
Member of the Scientific Advisory Board | 15.9yrs | no data | no data | |
Lead Independent Director | 6.3yrs | US$70.11k | 0% $ 0 | |
Independent Director | 10.4yrs | US$76.58k | 0.00023% $ 3.5 |
10.4yrs
Average Tenure
73yo
Average Age
Experienced Board: TRVN's board of directors are seasoned and experienced ( 10.4 years average tenure).
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/23 13:54 |
End of Day Share Price | 2024/12/23 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Trevena, Inc. is covered by 17 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Difei Yang | Aegis Capital Corporation |
Ying Huang | Barclays |
Jonathan Aschoff | Brean Capital |